Šta znači "Jasno"?
Životinja ne nosi mutaciju. To neće razviti bolest i neće ga prenijeti dalje.
Dilated Cardiomyopathy 4 (DCM4) in dogs is a genetic condition that affects the heart muscle, leading to weakened cardiac function and potential heart failure. Early DNA testing for DCM4 helps identify carriers and affected dogs, enabling responsible breeding decisions to reduce the risk of this serious disease. By using a reliable DNA test for DCM4, dog owners and breeders can ensure healthier bloodlines and improve the overall well-being of their pets. This genetic screening is essential for breeds prone to dilated cardiomyopathy, providing peace of mind through early detection. Stay proactive with DCM4 DNA testing to protect your dog’s heart health and longevity. Choose certified labs for accurate and fast results. Prioritize your dog’s health with DCM4 DNA testing today.
Dilated Cardiomyopathy 4 (DCM4) is a genetic condition in dogs that affects the heart muscle, leading to an enlarged and weakened heart. A DNA test can identify mutations associated with DCM4, helping breeders and veterinarians assess a dog's risk. Early detection through genetic testing allows for better management and care of affected dogs. This test is especially important for breeds prone to DCM4, such as Doberman Pinschers. Responsible breeding decisions based on DNA results can reduce the prevalence of this serious heart disease.
Ovaj DNK test je uključen počevši od našeg paketa Basic — i također je dio paketa Basic, Standard, Advanced, Complete.
Pogledajte pakete DNK testova →Dilated Cardiomyopathy 4 (DCM4) is a hereditary heart condition that primarily affects dogs, leading to an enlargement and weakening of the heart muscle. This condition impairs the heart's ability to pump blood effectively, which can result in congestive heart failure and other serious cardiovascular issues. Understanding the genetic basis of DCM4 is essential for early detection and management of the disease.
The genetic mutations associated with DCM4 can disrupt normal heart function and structure. Research has identified specific genes that are implicated in this condition, leading to the development of DNA tests that can help determine whether an individual dog carries these mutations. These genetic markers are crucial for breeders and veterinarians, as they can inform breeding decisions and health management strategies for affected dogs.
Dogs with DCM4 may exhibit a range of clinical symptoms, including lethargy, coughing, difficulty breathing, and exercise intolerance. As the condition progresses, more severe signs such as arrhythmias and sudden collapse can occur. Early recognition of these symptoms is vital for timely intervention and treatment, which may include medications or lifestyle changes to manage the dog's condition.
Early detection of DCM4 through genetic testing allows for proactive management of the disease. By identifying at-risk dogs, owners and veterinarians can monitor heart health closely and implement preventive measures. This can significantly improve the quality of life for affected dogs and may extend their lifespan. Additionally, responsible breeding practices can help reduce the prevalence of DCM4 in future generations.
While there is no cure for DCM4, various treatment options are available to manage the condition. Medications such as diuretics, ACE inhibitors, and beta-blockers can help alleviate symptoms and improve heart function. Dietary adjustments and regular veterinary check-ups are also crucial components of a comprehensive management plan. Owners are encouraged to work closely with their veterinarians to create an individualized treatment approach tailored to their dog's specific needs.
Dilated Cardiomyopathy 4 (DCM4) is a significant health concern for dogs, with a clear genetic component that underscores the importance of DNA testing. By understanding the implications of this condition and the available management options, dog owners can take proactive steps to ensure their pets lead healthy, fulfilling lives. Ongoing research in genetics and cardiology will continue to enhance our understanding of DCM4, paving the way for improved outcomes for affected dogs.
Životinja ne nosi mutaciju. To neće razviti bolest i neće ga prenijeti dalje.
Ne. Životinja je općenito zdrava, ali može prenijeti mutaciju na svoju potomstvo.
Nosi dvije mutirane kopije. Klinički znakovi se očekuju ovisno o bolest. Ne treba ga uzgajati.
Neke bolesti su spolno vezane, tako da njihova ekspresija varira u zavisnosti od toga spol životinje.
This DNA test detects the mutation associated with Dilated Cardiomyopathy 4 (DCM4) in order to identify clear, carrier, or at-risk animals.
DNK testiranje pomaže uzgajivačima da planiraju sigurnije parenje i smanjuju rizik od prenošenja mutacije na potomstvo.
Način nasljeđivanja prijavljen za ovaj test je autosomno recesivan.
This test analyses the mutation 60531090G>A.
Nije nužno. Tumačenje zavisi od obrasca nasljeđivanja i rezultirajućeg genotipa.
Niskanen, Julia E., et al. "Identification of novel genetic risk factors of dilated cardiomyopathy: from canine to human." Genome medicine 15.1 (2023): 73.
Vaša privatnost, vaš izbor
Koristimo osnovne kolačiće za pokretanje web stranice. Opcioni kolačići (kao što su dobavljači ugrađenog sadržaja) su podrazumevano onemogućeni i omogućeni su samo ako se slažete. Svoj izbor možete promijeniti bilo kada pomoću dugmeta „Kolačići“.
Potrebno za osnovne karakteristike i sigurnost. Uvijek omogućeno.
Poboljšava funkcije poput čuvanja preferencija ili ugrađivanja bez oglašavanja.
Pomaže nam da razumijemo upotrebu stranice. Podrazumevano onemogućeno.
Oglašavanje/praćenje na svim web lokacijama (neki video/mape ugrađeni). Podrazumevano onemogućeno.